Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian stock markets open firm
Tue, 25 Oct 09:30 am

Asian stock markets have opened the day on a mixed note. While stock market in Hong Kong (up 0.6%), China (up 0.4%) and Indonesia (up 0.3%) are trading firm, markets in Japan (down 0.3%) and South Korea (down 0.2%) are trading in the red. The Indian stock markets have opened the day on a firm note. Stocks in the technology space are leading the gains. However, consumer durables and capital goods stocks are trading in the red.

The BSE-Sensex is trading higher by 80 points (0.5%) and the NSE-Nifty is up by around 23 points (0.5%). While the BSE Mid Cap index is trading flat, the BSE Small Cap index is up by 0.2%. The rupee is trading at 49.70 to the US dollar.

Pharma companies have opened the day on a weak note with Pfizer, Novartis and GSK Pharma trading in the red. Drug-maker Pfizer has declared its results for the quarter ended September 2011 (2QFY12). The company has changed its accounting year from November ending to March ending with effect from December 2009. Hence the results are not strictly comparable. The sales of the company stood at Rs 2.7 bn for the quarter ended September 2011 against Rs 2.2 bn for the quarter ended August 2010. The net profit stood at Rs 469.9 m for quarter ended September 2011 against Rs 424.8 m for the quarter ended August 2010. All the 3 divisions -Pharmaceuticals, Animal Health and Services have performed quite well. Pfizer has a strong balance sheet with zero debt and a cash balance of Rs 8.7 bn at the end of September 2011.

Textile stocks have opened the day on a mixed note with Grasim Industries and Century Industries trading firm. However, Alok Industries and Arvind Ltd are facing selling pressure. Grasim Industries recently announced its financial results for the quarter ended September 2011. During the quarter, the company reported a rise of 29% YoY and 23% YoY in standalone sales and net profits respectively. However, high costs of raw materials, power and freight caused operating profits to grow at a lower rate of 10% YoY. The company's operating margins declined from 28.3% in 2QFY11 to 24.1% in 2QFY12. Higher other income, lower depreciation charges lifted the company's bottomline by 23% YoY. Net margins declined from 30% in 2QFY11 to 28.7% in 2QFY12.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian stock markets open firm". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.